Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GKOS

Glaukos (GKOS)

Glaukos Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GKOS
DateTimeSourceHeadlineSymbolCompany
02/14/20259:13AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
02/12/20253:42PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:GKOSGlaukos Corporation
01/24/20255:33PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
01/23/20256:00AMBusiness WireGlaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20NYSE:GKOSGlaukos Corporation
01/14/20253:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
01/14/20253:05PMBusiness WireGlaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical PlatformNYSE:GKOSGlaukos Corporation
01/02/20257:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
01/02/20257:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
01/02/20257:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
01/02/20257:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
12/23/20248:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
12/23/20246:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
12/23/20246:00AMBusiness WireGlaukos Submits New Drug Application to U.S. FDA for Epioxa™NYSE:GKOSGlaukos Corporation
12/20/20243:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
12/20/20243:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
12/17/20246:00AMBusiness WireGlaukos Announces Participation in the J.P. Morgan Healthcare ConferenceNYSE:GKOSGlaukos Corporation
12/13/20246:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
12/11/202411:32AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
12/09/20245:30AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
12/03/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
11/15/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
11/08/20246:00AMBusiness WireGlaukos Announces Participation in Upcoming Investor ConferencesNYSE:GKOSGlaukos Corporation
11/04/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
11/04/20243:05PMBusiness WireGlaukos Announces Third Quarter 2024 Financial ResultsNYSE:GKOSGlaukos Corporation
11/01/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
10/30/20243:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
10/16/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
10/16/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
10/16/20243:05PMBusiness WireGlaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and SafetyNYSE:GKOSGlaukos Corporation
10/14/20246:00AMBusiness WireGlaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual MeetingNYSE:GKOSGlaukos Corporation
 Showing the most relevant articles for your search:NYSE:GKOS

Your Recent History

Delayed Upgrade Clock